Webinar, Panel
Lessons Learned from COVID-19: Are There Silver Linings for Biomedical Innovation?
- Biomedical R&D will institutionalize lessons from the COVID-19 acceleration to address future infectious disease outbreaks, leveraging a "shark tank" model for rapid technology development and partnership formation without typical legal constraints.
- A future pandemic is considered probable, though specific timing, pathogen, or clinical impact of variants remains unknown, necessitating continuous monitoring and a shift from emergency-unique behaviors to long-term institutionalization.
- Future clinical research requires immediate investment in sustainable, community-based infrastructure and decentralized trials using digital technologies to ensure diverse population enrollment, as capacity cannot be established mid-crisis.
- Industry and public sectors aim to maintain global emergency triggers for central coordination, enabling rapid randomization of the first patient and the use of platform trials ready for quick deployment in "less emergent situations."
- The NIH is committing to workforce recruitment and retention reforms to address structural racism, having previously achieved 35-37% diversity in vaccine trials through dedicated spending and special commitment.
- Cancer research outcomes face the risk of new diagnoses and later-stage detection due to pandemic-related screening decreases, driving the need for accelerated new trials and simplified, meaningful trial designs to avoid poorly powered studies.
- The FDA and partners anticipate a recovery phase for supply chain inspections while requiring a more rigorous approach to clinical trial design to eliminate duplicative and sloppy practices that compromise accuracy and trust.
- Current policy behaviors born of emergency urgency are at risk of disappearing if not actively preserved, with a critical "moment in time" required immediately to capture pandemic lessons before opportunities are lost.
- Underfunded foundations like the Reagan Udall Foundation require increased financial support to maintain utility, while the private sector seeks to carry forward collaboration, data sharing, and manufacturing flexibility observed during the pandemic.
- While the industry is galvanized to build sustainable infrastructure through public-private partnerships, experts note that establishing this foundation is not a short-term endeavor ("on a dime") and requires significant, sustained effort.